EmCyte adipose lipoplasty harvesting system gains FDA clearance for neurosurgery, orthopedics

Alan Condon -   Print  |

The FDA cleared EmCyte's Progenikine Concentrating System for adipose lipoplasty for procedures in several specialties including neurosurgery and orthopedics.

Three things to know:

1. Progenikine is intended for extraction and centrifugal preparation of adipose concentrate at the point of care.

2. The system can completely remove oil contaminants and residue to obtain a concentrated adipose sample.

3. EmCyte is headquartered in Fort Myers, Fla., and develops systems for autologous regenerative biologics.

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers

Featured Podcast